Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Ross Levine is the Laurence Joseph Dineen Chair in Leukemia Research at Memorial Sloan Kettering Cancer Center. His clinical interest lies in the genetics and treatment of myeloid malignant diseases, including myeloproliferative neoplasms - polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (MF). Dr. Levine received his medical degree from Johns Hopkins School of Medicine followed by a residency at Massachusetts General Hospital and fellowships at Dana-Farber Cancer Institute and Brigham and Women’s Hospital/Harvard Medical School. Dr. Levine is board certified in internal medicine, hematology, and medical oncology.